DK1108425T3 - Nye, stabile flerenhedspræparater, der indeholder substituerede benzimidazoler - Google Patents

Nye, stabile flerenhedspræparater, der indeholder substituerede benzimidazoler

Info

Publication number
DK1108425T3
DK1108425T3 DK99670010T DK99670010T DK1108425T3 DK 1108425 T3 DK1108425 T3 DK 1108425T3 DK 99670010 T DK99670010 T DK 99670010T DK 99670010 T DK99670010 T DK 99670010T DK 1108425 T3 DK1108425 T3 DK 1108425T3
Authority
DK
Denmark
Prior art keywords
coated
pharmaceutical preparations
preparations containing
layer
containing substituted
Prior art date
Application number
DK99670010T
Other languages
Danish (da)
English (en)
Inventor
Ramalho De Oliveira Mar Caeiro
Mendes Carla Patrici Goncalves
Original Assignee
Medinfar Produtos Farmaceutico
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8242620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1108425(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medinfar Produtos Farmaceutico filed Critical Medinfar Produtos Farmaceutico
Application granted granted Critical
Publication of DK1108425T3 publication Critical patent/DK1108425T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK99670010T 1999-12-16 1999-12-16 Nye, stabile flerenhedspræparater, der indeholder substituerede benzimidazoler DK1108425T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99670010A EP1108425B1 (de) 1999-12-16 1999-12-16 Neue stabile mehreinheitliche substituierte Benzimidazole enthaltende pharmazeutische Präparate

Publications (1)

Publication Number Publication Date
DK1108425T3 true DK1108425T3 (da) 2005-09-26

Family

ID=8242620

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99670010T DK1108425T3 (da) 1999-12-16 1999-12-16 Nye, stabile flerenhedspræparater, der indeholder substituerede benzimidazoler

Country Status (7)

Country Link
US (1) US6379705B1 (de)
EP (1) EP1108425B1 (de)
AT (1) ATE297194T1 (de)
DE (1) DE69925740T2 (de)
DK (1) DK1108425T3 (de)
ES (1) ES2244167T3 (de)
PT (1) PT1108425E (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
AU2001296908A1 (en) * 2000-09-29 2002-04-08 Geneva Pharmaceuticals, Inc. Proton pump inhibitor formulation
US8105626B2 (en) * 2001-10-17 2012-01-31 Takeda Pharmaceutical Company Limited Granules containing acid-unstable chemical in large amount
KR100479637B1 (ko) * 2002-02-01 2005-03-31 한국화학연구원 란소프라졸을 함유하는 경구제제 및 그의 제조방법
KR100434904B1 (ko) * 2002-05-30 2004-06-11 주식회사 대웅 안정화된 란소프라졸을 함유하는 장용성 제제
US20030228363A1 (en) * 2002-06-07 2003-12-11 Patel Mahendra R. Stabilized pharmaceutical compositons containing benzimidazole compounds
US7732474B2 (en) * 2002-08-02 2010-06-08 Ratiopharm, Gmbh Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation
US20050191353A1 (en) * 2002-08-16 2005-09-01 Amit Krishna Antarkar Process for manufacture of stable oral multiple unit pharmaceutical composition containing benzimidazoles
EP1552833B1 (de) * 2002-10-16 2016-12-28 Takeda Pharmaceutical Company Limited Herstellung eines amorphen, optisch aktiven Isomers von Lansoprazol
US20040146558A1 (en) * 2003-01-28 2004-07-29 Kyowa Pharmaceutical Co., Ltd. Oral enteric-coated preparation
EP1594479A1 (de) * 2003-01-31 2005-11-16 Ranbaxy Laboratories Limited Stabile orale benzimidazol-zusammensetzungen und verfahren zu ihrer herstellung
JP4808612B2 (ja) * 2003-04-25 2011-11-02 田辺三菱製薬株式会社 アルキレンジオキシベンゼン誘導体を含む経口投与用組成物
AR045068A1 (es) * 2003-07-23 2005-10-12 Univ Missouri Formulacion de liberacion inmediata de composiciones farmaceuticas
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US20060003002A1 (en) * 2003-11-03 2006-01-05 Lipocine, Inc. Pharmaceutical compositions with synchronized solubilizer release
US20050214372A1 (en) * 2004-03-03 2005-09-29 Simona Di Capua Stable pharmaceutical composition comprising an acid labile drug
WO2005107721A2 (en) 2004-05-07 2005-11-17 Altana Pharma Ag Pharmaceutical dosage form comprising pellets as well as its manufacturing process
CA2469427A1 (en) * 2004-06-01 2005-12-01 Pharmascience Inc. Dry mixed dosage form containing benzimidazole derivatives
US9040564B2 (en) * 2005-04-28 2015-05-26 Eisai R&D Management Co., Ltd. Stabilized composition
EP1785135A1 (de) * 2005-11-10 2007-05-16 Laboratorios Del Dr. Esteve, S.A. Neue Lanzoprazol enthaltende stabilisierte galenische Formulierungen und ihre Herstellung
WO2007138606A2 (en) * 2006-06-01 2007-12-06 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
EP2257220B1 (de) * 2008-03-13 2017-06-14 Liebel-Flarsheim Company LLC Fussbetätigte multifunktionssteuerung für bildgebungssystem
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
PL2773348T3 (pl) 2011-11-02 2018-07-31 Laboratorios Del. Dr. Esteve, S.A. Kompozycja farmaceutyczna omeprazolu
GB201306720D0 (en) 2013-04-12 2013-05-29 Special Products Ltd Formulation
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
EP3292862A1 (de) 2016-09-07 2018-03-14 Sandoz Ag Omeprazolformulierungen
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
US12150945B2 (en) 2018-07-20 2024-11-26 Lipocine Inc. Liver disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
YU48263B (sh) * 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
ATE156707T1 (de) * 1991-06-21 1997-08-15 Ilsan Ilac Ve Hammaddeleri San Neues galenisches verfahren für omeprazol enthaltende pellets
FR2692146B1 (fr) * 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
CZ289804B6 (cs) * 1994-07-08 2002-04-17 Astrazeneca Ab Multijednotková tabletovaná dávková forma I
ES2094694B1 (es) * 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
PT101826A (pt) * 1996-02-06 1997-09-30 Medinfar Produtos Farmaceutico Processo para a preparacao de microgranulos contendo omeprazole
ZA979937B (en) * 1996-11-06 1999-05-18 Sharmatek Inc Delayed delivery system for acid-sensitive drugs
PT101965A (pt) * 1997-02-06 1998-09-30 Medinfar Produtos Farmaceutico Novas formulacoes farmaceuticas estaveis de microgranulos contendo omeprazole

Also Published As

Publication number Publication date
ATE297194T1 (de) 2005-06-15
DE69925740T2 (de) 2006-05-11
HK1039742A1 (en) 2002-05-10
EP1108425A1 (de) 2001-06-20
DE69925740D1 (de) 2005-07-14
EP1108425B1 (de) 2005-06-08
PT1108425E (pt) 2005-10-31
US6379705B1 (en) 2002-04-30
ES2244167T3 (es) 2005-12-01

Similar Documents

Publication Publication Date Title
ATE297194T1 (de) Neue stabile mehreinheitliche substituierte benzimidazole enthaltende pharmazeutische präparate
EP2112920B1 (de) Protonenpumpeninhibitoren enthaltende kapseln, die verschieden aufgebaute untereinheiten zur verzögerten wirkstofffreisetzung enthalten
ES2201200T3 (es) Composicion farmaceutica que contiene un omeprazol labil al acido, y procedimiento para su preparacion.
ES2189232T5 (es) Microgránulos de omeprazol protegidos gástricamente, procedimiento de obtención y preparaciones farmacéuticas
EP1341524B1 (de) Pharmazeutische zubereitung in form einer paste mit einem säurelabilen wirkstoff
CA2453117A1 (en) Oral dosage forms comprising a benzimidazole and buffer
IE921733A1 (en) Oral presentation forms for acid-unstable active compounds
NO20023313L (no) Nye substituerte benzimidazol doseringsformer og fremgangsmåte for anvendelse av samme
BR9910723A (pt) Composição farmacêutica oral, estável, contendo um composto de piridilsulfinil benzimidazol substituìdo
JP2011157390A (ja) 胃液において不溶性の微小顆粒、その調製方法、および薬学的調製物
CA2290824A1 (en) Benzimidazole pharmaceutical composition and process of preparation
KR20030059318A (ko) 산 불안정성 활성 성분을 포함하는 현탁액 형태의 약학 제제
Thitiphuree et al. Esomeprazole, a new proton pump inhibitor: pharmacological characteristics and clinical efficacy
US20010053387A1 (en) Benzimidazole pharmaceutical composition and process of prepatation
WO2005034924A1 (en) Enteric coated pellets comprising esomeprazole, hard gelatin capsule containing them, and method of preparation
DE69907479D1 (de) Piroxicam enthaltende gastrointestinale Zubereitung aus merheren Einheiten bestehend
CZ295266B6 (cs) Stabilní galenické přípravky obsahující benzimidazol a způsob jejich přípravy
JP2005522462A (ja) 気道疾患の治療のためのプロトンポンプ阻害剤の使用
WO2019216837A1 (en) Novel pharmaceutical compositions
WO2020022974A2 (en) A pharmaceutical composition comprising prucalopride and a proton pump inhibitor